What notable advantages define Japanese healthcare resources? When facing diverse healthcare and health management needs, how can you identify the right institutions and strategic partners?
The Zhenghe · 28th China International Medical Tourism Fair (CMTF Beijing) will be held from November 19 to 21 at the China International Exhibition Center (Chaoyang Hall) in Beijing.
As an essential pavilion of the exhibition, a premier delegation of Japanese hospitals and institutions will showcase leading innovations across cancer therapy, precision health screenings, assisted reproductive technology (ART), cell therapy, stem cells, regenerative medicine, NMN supplements, advanced pharmaceuticals, anti-aging therapies, and aesthetic plastic surgery.
This event presents an exceptional opportunity to explore Japanese medical capabilities up close, establish cross-border partnerships, and discover new business horizons. We cordially invite you to join us!
👆Scan the QR code to contact the organizer
Register for Visiting or Click Here
One-Stop Access to Japanese Medical Resources—Right in Beijing
Below is an introduction to the first batch of exhibitors in the Japanese medical delegation: Seta Clinic Tokyo, General Southern Tohoku Hospital, Iwamoto Internal Medicine Clinic, Jundo Co., Ltd., Ginza Bio-Regen Clinic, Belle Aesthetic Surgery, YSYC Yamashita Reproductive Hospital, Morozumi Ladies Clinic, Matsumoto IVF Clinic, Shinbashi Shoji, iRxMedicine, Matsumoto Pharmaceutical, Shuiyin Healthcare, and HELENE Clinic.
1. Seta Clinic Tokyo (Booth No.A86–87)
Highlights: Specialized oncology institution dedicated to cancer immune cell therapy, delivering tailored treatment regimens for every patient.
Established in 1999 as a leading Japanese specialty clinic for immuno-cell cancer therapy, Seta Clinic has treated thousands of oncology patients. By evaluating pre-treatment immune profiles and cancer histological classifications alongside ongoing clinical therapies, the clinic develops individualized, optimized treatment strategies. The medical team consists of experienced cancer immunotherapy specialists from renowned university hospitals and dedicated cancer institutes.
2. General Southern Tohoku Hospital (Booth No.T11B)
Highlights: Proton beam therapy, Boron Neutron Capture Therapy (BNCT).
The Southern Tohoku BNCT Research Center, affiliated with the Southern Tohoku Research Institute for Neuroscience, introduced advanced accelerator-based BNCT systems designed for recurrent and advanced malignancies. Supported by the Fukushima Prefectural Government, the foundation took the lead in adopting the cyclotron-based BNCT system jointly developed by Kyoto University and Sumitomo Heavy Industries.
Clinical trials commenced in January 2016 and successfully concluded in 2018, completing one of the highest numbers of accelerator-based BNCT treatments globally. In March 2020, the facility received official medical device approval from the Ministry of Health, Labour and Welfare (MHLW), becoming a pioneering private medical institution in Japan to provide accelerator-based BNCT therapies.
3. Iwamoto Internal Medicine Clinic (Booth No. A47)
Highlights: Liver cancer interventional oncology, stem-cell-based regenerative therapy for liver cirrhosis, and male/female vitality management.
Located in Fukuoka, Japan, and established in 1990, Iwamoto Internal Medicine Clinic has specialized in liver diseases and hepatocellular carcinoma for over 35 years. The clinic is widely recognized for combining deep clinical expertise with precise endovascular interventional procedures. It performs signature treatments such as simultaneous portal vein and hepatic artery embolization, as well as NEW-FP hepatic arterial infusion chemotherapy (HAIC), offering personalized therapeutic options for patients with complex liver malignancies. Its clinical outcomes in simultaneous embolization have been published in the peer-reviewed medical journal Cancer.
In regenerative medicine, leveraging its interventional catheter expertise, the clinic delivers stem cells via targeted arterial infusion for cirrhosis management, alongside vitality programs addressing male physical and sexual function, female ovarian and uterine health, perimenopausal well-being, metabolic health, and long-term vitality.
4. Jundo Co., Ltd. (Booth No.A62)
Highlights: Specialized inbound medical coordination for oncology patients, high-end precision cancer screenings, and stem cell therapies.
Centering its mission on cancer prevention, early screening, and treatment to optimize patients' quality of life, Jundo Co., Ltd. operates with the backing of a multidisciplinary medical panel. Founded in 2013 within the Kobe Biomedical Innovation Cluster (KBIC) on Port Island—a core national urban revitalization project of Japan—the company is surrounded by more than 200 medical and research institutions, providing an unparalleled environment for advanced care delivery. Recognized as a benchmark enterprise in Kobe, Jundo has been featured by major media outlets including NHK, The New York Times, The Nikkei, Nikkei Business Daily, and TIME magazine. Jundo focuses heavily on cross-border coordination for international oncology patients, having supported nearly 1,000 patients with advanced cancer through proprietary treatment resources and comprehensive clinical data networks.
5. Ginza Bio-Regen Clinic, Tokyo (Booth No. T32)
Highlights: Mesenchymal stem cells (MSCs), NK immune cells, fibroblasts, conditioned culture supernatants, and anti-aging IV infusions.
Rooted in Tokyo's Ginza district and focused on the "100-Year Life Era," Ginza Bio-Regen Clinic offers end-to-end, high-end regenerative medical services. From accurate pre-treatment assessments and tailored protocols designed by senior specialists to supportive interventions during treatment and long-term post-therapy follow-up, the clinic maintains rigorous standards for safety and clinical outcomes. The clinic collaborates with major Japanese universities on clinical research, partners with university-affiliated hospitals for advanced diagnostic examinations, and features a dedicated digital health portal for full-course monitoring, covering cell culture, transportation, administration, and vital tracking.
6. Belle Aesthetic Surgery (Booth No.: B34–35)
Highlights: Gold Thread Rejuvenation, stem cell therapies, blood purification, and proprietary regenerative medical aesthetic products.
With more than 20 years of dedication to regenerative aesthetics, Belle Clinic advocates non-surgical, long-lasting anti-aging philosophies uniting internal vitality and external aesthetic refinement. Grounded in clinical expertise and strict patient safety standards, the clinic listens closely to each patient's goals, designing personalized aesthetic and anti-aging plans. From anti-aging skin rejuvenation therapies to precision aesthetic procedures, the clinic delivers tailored regimens grounded in comprehensive clinical evaluations.
7. YSYC Yamashita Reproductive Hospital (Booth No.: T5)
YSYC utilizes natural-cycle assisted reproductive treatment protocols (supported by Towako Group technology). Its clinical offerings cover everything from basic infertility assessments to advanced assisted reproductive technology (ART):
Advanced Reproductive Technology (ART / IVF): Equipped with an independent Advanced Reproductive Medical Research Institute, YSYC champions "minimal-stimulation / natural-cycle egg retrieval" to minimize pharmaceutical burdens on the body while focusing on high-quality oocytes.
General Infertility Treatments: For early-stage or mild infertility conditions, the hospital provides gentle, minimally invasive solutions (such as timed intercourse guidance and intrauterine insemination).
Male Infertility & Fertility Preservation
Comprehensive Diagnostic Screening for Infertility Etiologies
8. Morozumi Ladies Clinic (Booth No.: A5)
Highlights: Third-generation IVF (PGT), Sino-Japanese synchronized ovarian stimulation, and personalized assisted reproductive protocols.
Situated in Tokyo's Ginza district, Morozumi Ladies Clinic is a prominent Japanese fertility specialty institution. Dedicated to helping intended parents realize their family-building goals, Morozumi is recognized for its laboratory technologies, experienced physician teams, and favorable clinical pregnancy success rates.
9. Matsumoto IVF Clinic (Booth No.: B70)
Highlights: Matsumoto IVF Clinic Tokyo & Keyu Youdao Co., Ltd.
Matsumoto IVF Clinic brings 26 years of clinical reproductive experience to its focus on egg freezing, fertility preservation, and IVF protocols. Keyu Youdao has specialized in medical travel to Japan for over a decade, providing cross-border referrals and full-service coordination across fertility care, oncology, cardiovascular and cerebrovascular diseases, orthopedics, diabetes, and other specialized overseas medical needs.
10. Shinbashi Shoji (Booth No.: B42–43)
Highlights: Age reversal and longevity, healthy weight management, chronic disease conditioning, immune support, renal health restoration, and sleep optimization.
Founded in 1999, the Hamashoku product series is a heritage brand with over 25 years of history, honored repeatedly by Japanese regulatory authorities. Since introducing its formulations to Chinese consumers in the 1990s, Hamashoku has adhered to the philosophy of "nourishing wellness through nutrition," maintaining strict artisanal craftsmanship. Its continuous formulation refinements have garnered consumer trust, earning multiple industry recognitions at the China Health Industry Entrepreneurs Annual Conference and Healthy China conferences. Awards such as Industry Influential Brand, 2021 Preferred Brand in Nutritional Health, Artisanal Quality Product, and Annual Gold Award for Most Influential Brand reflect the market standing of the Hamashoku portfolio.
11. iRxMedicine (Booth No.: A51)
Highlights: A Japanese pharmaceutical sourcing platform with a 25-year track record, operating brick-and-mortar pharmacies in Japan with international pharmaceutical cold-chain distribution.
With a company history spanning 45 years and 25 years of specialized pharmaceutical import and export agency experience, this enterprise provides compliant international sourcing and delivery services for physicians, patients, pharmaceutical companies, distributors, and healthcare providers worldwide. The group operates directly owned pharmacies in Tokyo staffed by dedicated full-time pharmacists, supplying OTC medications, prescription pharmaceuticals, oncology therapeutics, and Kampo formulations. Its direct procurement-to-distribution supply model minimizes operational margins, delivering distinct pricing and delivery advantages.
12. Matsumoto Pharmaceutical (Booth No.: A6)
Highlights: Specialized dietary supplements, clinical pharmaceuticals, and advanced biotherapeutics.
13. Shuiyin Healthcare (Booth No.: B61)
Highlights: A collaborative cross-border regenerative health network linking Mainland China, Hong Kong, Tokyo, and Kobe.
Offers tailored coordination for autologous stem cell infusions, NK cell therapies, ultra-early cancer screening protocols, low-side-effect oncological therapies, HGF stem cell supernatants, NAD+, and NMN supplementation.
14. HELENE Clinic Omotesando, Tokyo
Highlights: Clinical applications of autologous stem cell therapies, personalized longevity protocols, and frontier regenerative technologies.
What Can You Gain by Attending?
If you are tracking Japanese healthcare developments, cross-border patient referral opportunities, assisted reproduction, advanced cancer treatment, stem cell therapy, regenerative medicine, functional nutrition, and anti-aging innovations, we welcome you to join us on-site to connect face-to-face with the Japanese delegation and global healthcare providers.
Join us November 19–21 at the Zhenghe · 28th China International Medical Tourism Fair (CMTF Beijing)!
How to Participate: Click here to learn more.
